GLP1R and type 2 diabetes mellitus: Actually, therapeutic agents such as GLP-1R agonists (GLP-1RAs) and DPP-IV inhibitors are largely employed in the treatment of type 2 diabetes and obesity [3,4,5,11,12,13].